Palbociclib: an evidence-based review of its potential in the treatment of breast cancer
Karen A Cadoo, Ayca Gucalp, Tiffany A TrainaBreast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY, USAAbstract: Cellular proliferation, growth, and division following DNA (deoxyribonucleic acid) damage are tightly contro...
Guardado en:
Autores principales: | Cadoo KA, Gucalp A, Traina TA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/967a4806d15f4e5db66396534f057aa7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical evidence of the efficacy of everolimus and its potential in the treatment of breast cancer
por: Saksena R, et al.
Publicado: (2013) -
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
por: Criscitiello C, et al.
Publicado: (2018) -
Profile of neratinib and its potential in the treatment of breast cancer
por: Feldinger K, et al.
Publicado: (2015) -
Profile of palbociclib in the treatment of metastatic breast cancer
por: Ehab M, et al.
Publicado: (2016) -
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date
por: Criscitiello C, et al.
Publicado: (2018)